Retrospective Study
Copyright ©The Author(s) 2022.
World J Radiol. Sep 28, 2022; 14(9): 319-328
Published online Sep 28, 2022. doi: 10.4329/wjr.v14.i9.319
Table 2 The sensitivity, specificity, positive predictive value and negative predictive value per Ovarian-Adnexal Reporting and Data System category for each reader on the post-training assessment
Post training
ORADS 1, %
ORADS 2, %
ORADS 3, %
ORADS 4, %
ORADS 5, %
Sensitivity
R1100 (69.2 to 100)100 (69.2 to 100)100 (59 to 100)92 (61.5 to 99.8)73 (39 to 94)
R290 (55.5 to 99.8)90 (55.5 to 99.8)86 (42.1 to 99.6)92 (61.5 to 99.8)82 (48.2 to 97.7)
R3100 (69.2 to 100)100 (69.2 to 100)100 (59 to 100)75 (42.8 to 94.5) 64 (30.8 to 89.1)
Specificity
R1100 (91.2 to 100)95 (83.1 to 99.4)98 (87.7 to 99.9)97 (86.2 to 99.9)100 (91 to 100)
R2100 (91.2 to 100)98 (86.8 to 99.9)93 (80.9 to 98.5)95 (82.3 to 99.4)100 (91 to 100)
R3100 (91.2 to 100)95 (83.1 to 99.4)91 (77.9 to 97.4)97 (86.2 to 99.9)100 (91 to 100)
PPV
R110083 (56.4 to 95.1)88 (50.2 to 98)92 (61.2 to 98.7)100
R210090 (56.2 to 98.4)67 (39.2 to 86.1)85 (58.5 to 95.5)100
R310083 (56.4 to 95.1)64 (40.8 to 81.7)90 (55.9 to 98.5)100
NPV
R110010010097 (85 to 99.6)93 (83.2 to 97.2)
R298 (86.2 to 99.6)98 (85.9 to 99.6)98 (86.7 to 99.6)97 (84.6 to 99.6)95 (84.8 to 98.6)
R310010010093 (82.2 to 97.1)91 (81.7 to 95.5)